Rashid H, Kitano H, Lee K Hoon, Nii S, Shigematsu T, Kadomura K, Yamaguchi A, Matsuyama M
Laboratory of Marine Biology, Faculty of Agriculture, Kyushu University, Hakozaki, Higashi-Ku, Fukuoka, Japan.
Sex Dev. 2007;1(5):311-22. doi: 10.1159/000108935.
In order to assess the involvement of aromatase CYP19 isoforms and endogenous sex steroids in gonadal sex differentiation and development of the Japanese fugu (Takifugu rubripes), an aromatase inhibitor (AI, fadrozole) was administered to developing fishes from the 'first feeding' till the 100th day after hatching. It was observed that ovarian cavity formation was inhibited by fadrozole at doses of 500 and 1000 microg/g diet, which was followed by testicular differentiation in all treated fugu. In the non-treated fugu, CYP19A was predominantly expressed in the ovary and CYP19B in the brain (in both sexes), although both were expressed interchangeably at low levels. An exceptionally high expression of CYP19B was also evident in testis throughout the study period. Both forms of CYP19 mRNA showed low levels of expression in brain and gonad with no significant differences between the two AI treatments. AI treatment inhibited CYP19A mRNA in trunk during the crucial period of ovarian cavity formation and CYP19B in gonad and brain by the end of gonadal sex differentiation. An elevation of testosterone and 11-ketotestosterone was observed which can be associated with the down-regulation of the circulating 17beta-estradiol production during the AI treatment period. After stopping AI treatment, both circulating estrogen and androgen were normalized. The current results suggest that suppression of CYP19A before and during morphological sex differentiation inhibits ovarian cavity formation in fugu. Furthermore, non-detectable limits of 17beta-estradiol and high testosterone levels by the end of the gonadal differentiation period can be ascribed to inhibition of CYP19B, suggesting that conversion of 17beta-estradiol from testosterone is plausibly regulated by CYP19B, and that this factor (CYP19B) may play an important role in AI-induced testicular development after gonadal sex differentiation through regulation of the testosterone-17beta-estradiol balance in fugu.
为了评估芳香化酶CYP19同工型和内源性性类固醇在日本河豚(红鳍东方鲀)性腺性别分化和发育中的作用,从“初次摄食”开始至孵化后第100天,给发育中的河豚投喂芳香化酶抑制剂(AI,法倔唑)。观察到,剂量为500和1000微克/克饲料的法倔唑抑制了卵巢腔形成,随后所有处理过的河豚均发生了睾丸分化。在未处理的河豚中,CYP19A主要在卵巢中表达,CYP19B在脑(两性)中表达,尽管二者在低水平上可互换表达。在整个研究期间,CYP19B在睾丸中的表达也异常高。两种形式的CYP19 mRNA在脑和性腺中的表达水平均较低,两种AI处理之间无显著差异。AI处理在卵巢腔形成的关键期抑制了躯干中的CYP19A mRNA,并在性腺性别分化结束时抑制了性腺和脑中的CYP19B。观察到睾酮和11-酮睾酮升高,这可能与AI处理期间循环17β-雌二醇生成的下调有关。停止AI处理后,循环雌激素和雄激素均恢复正常。目前的结果表明,在形态学性别分化之前和期间抑制CYP19A可抑制河豚卵巢腔形成。此外,性腺分化期结束时17β-雌二醇的不可检测水平和高睾酮水平可归因于CYP19B的抑制,这表明睾酮向17β-雌二醇的转化可能受CYP19B调控,并且该因子(CYP19B)可能通过调节河豚睾酮-17β-雌二醇平衡,在性腺性别分化后AI诱导的睾丸发育中发挥重要作用。